Targeting the pericyte antigen DLK1 with an alpha type-1 polarized dendritic cell vaccine results in tumor vascular modulation and protection against colon cancer progression
Amanda L. McCormick(Texas Tech University), Devin B. Lowe(Texas Tech University)
Cited by 9